Teva Pharmaceutical: Dividends, Earnings And Valuation Analysis

. . . .

Teva Pharmaceutical (TEVA): A Dividend Contender with 13 Consecutive Years of Dividend Increases

Since dividends are paid out of earnings, a clear perspective of a company’s historical earnings growth record is a vital component of a dividend investor’s prudent due diligence process. The following graph plots Teva Pharmaceutical’s earnings per share since 1998. A quick glance to the right of the graph shows that Teva Pharmaceutical has increased earnings at a compounded rate of 23.1% (see purple circle on graph) per annum.

. . . .

(Click here to view entire article on Seeking Alpha.)

Please follow and like us:

Leave a Reply